News

On April 10, 2024, we hosted the Kick-off meeting of CRC 392 at the Institute of Organic Chemistry at the University of Würzburg.

The Bayer foundation presented the Hansen Family Award 2023 to Prof. Claudia Höbartner

On December 19th, 2023 Hermann Neitz successfully defended his PhD on "Hydrophobic recognition motifs in functionalized DNA". Many congratulations and all best wishes for a bright future!

On October 30th, 2023 Carolin SCheitl successfully defended her PhD on "In vitro selected ribozymes for RNA methylation and labeling". Many congratulations and all best wishes for a bright future!

Congratulations! Julia Dietzsch is among the three poster awardees at the CMMC Symposium 2023 in Molecular Medicine!

Zum XI. Nucleinsäurechemietreffen der DNG am 14.-15.9.2023 versammelten sich ca 120 Teilnehmer an der Universität Würzburg um sich über ihre neuesten Forschungsergebnisse auszutauschen.

We report the ribozyme SAMURI which uses a synthetic SAM analogue as cofactor to make RNA in cells accessible for labeling by Click Chemistry. Just published in Nature Chemistry. Congrats to Takumi Okuda and all coauthors!

Falling Walls 2023 Winner | Life Science

Unlocking RNA’s potential: Claudia Höbartner’s exploration of functional nucleic acids

Our project "Molecular evolution of RNA-modifying ribozymes" is among this year's Falling Walls Finalists in the Life Science category.

On April 28th, 2023 Florian Seitz successfully defended his PhD on "Synthesis, enzymatic recognition and antiviral properties of modified purine nucleosides". Congratulations and all best wishes for a bright future!

On April 3rd, 2023 Carina Stiller successfully defended her PhD on "Synthesis and applications of modified nucleosides and RNA nucleotides". Congratulations and all best wishes for a bright future!

Claudia Höbartner is being honoured for her outstanding research on the nucleic acids DNA and RNA: She receives the prestigious Leibniz Prize by the DFG.

Claudia has been awarded the 2022 Meyerhof Medal from the Max Planck Institute for Medical Research.

On August 18th, 2022 Anam Liaqat successfully defended her PhD on "Artificial Evolution of Nucleic Acid Catalysts and their Use for Studying RNA". Congratulations and all best wishes for a bright future!

Die Kristallstruktur des Methyltransferase-Ribozyms MTR1 zeigt die erstaunliche Architektur der Bindungsstasche für den Cofaktor und einen unerwarteten Mechanismus der Methylgruppenübertragung.